Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T78332 |
Eftilagimod alfa
IMP321,LAG-3Ig |
||
Eftilagimod alfa为重组LAG-3Ig融合蛋白,具有MHC II 类分子结合能力。该药物通过介导抗原提呈细胞(APC)的激活进而激活CD8 T细胞,可用于研究转移性黑色素瘤及转移性乳腺癌。 | |||
T68322 | IMP-321 | ||
IMP-321 is a soluble dimeric recombinant form of LAG-3 and first-in-class antigen presenting cell activator. |